Welcome to our dedicated page for SCHWAB CHARLES SEC filings (Ticker: SCHW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCHWAB CHARLES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCHWAB CHARLES's regulatory disclosures and financial reporting.
Charles Schwab Corp director equity compensation update: A company director reported receiving 431 restricted stock units (RSUs) of Charles Schwab Corp common stock on 01/02/2026 under the Directors' Deferred Compensation Plan II. These RSUs were received in lieu of cash director fees and are held in a rabbi trust for the director's benefit, to be distributed when he leaves the Board of Directors. Following this transaction, the director beneficially owns 150,782.73 RSUs, which includes 440.59 RSUs acquired through dividend reinvestment in November 2025. Each RSU represents the right to receive one share of company stock.
Charles Schwab Corp disclosed a director equity grant in the form of restricted stock units. On 01/02/2026, a director received 357 restricted stock units, each representing the right to receive one share of common stock. These units were granted under the Directors' Deferred Compensation Plan II and are held in a rabbi trust for the director’s benefit.
The RSUs were issued in lieu of cash director fees and will be distributed to the director when he leaves the Board of Directors, consistent with the plan’s terms. Following this transaction, the director beneficially owned 12,417.76 restricted stock units, which includes 35.34 RSUs acquired through dividend reinvestment in November 2025.
Charles Schwab Corporation director reports new stock option grant. A company director filed a Form 4 disclosing receipt of a nonqualified stock option to buy 1,317 shares of Schwab common stock on 01/02/2026 at an exercise price of $101.57 per share. The option was granted under the Directors' Deferred Compensation Plan II, vested immediately on the grant date, and is scheduled to expire on 01/02/2036. The filing states the option was received in lieu of cash compensation otherwise payable as director fees and is held as a direct ownership position.
Charles Schwab Corporation officer Form 4 shows an option exercise and related share sale. On 12/23/2025, the reporting person exercised a nonqualified stock option to buy 2,000 shares of Charles Schwab common stock at $46.39 per share, granted under the company’s 2013 Stock Incentive Plan and expiring on 11/01/2028.
The 2,000 shares received were contributed to a trust, and the trust then sold 2,000 shares of common stock on the same date in multiple trades at a weighted average price of $102.0108 per share under a Rule 10b5‑1 trading plan adopted on May 28, 2025. After these transactions, the reporting person held 43,340 shares directly and 11,923 shares indirectly through the trust, and 2,000 stock options remained beneficially owned.
The Charles Schwab Corporation insider plans to sell common stock under Rule 144. A notice reports a proposed sale of 4,000 shares of Schwab common stock through The Charles Schwab Corporation as broker on the NYSE, with an aggregate market value of $414,020.00. The shares relate to a stock option exercise from the issuer on 12/23/2025. The notice also shows that the seller previously sold 3,072 shares of Schwab common stock on 11/12/2025 for gross proceeds of $301,056.00. Schwab had 1,776,936,770 shares of common stock outstanding at the time listed.
Charles Schwab Corp director reports option exercise and trust transfer. A company director exercised a nonqualified stock option for 1,922 shares of common stock at an exercise price of $31.98 per share on 12/16/2025, coded as transaction type “M”. Following this transaction, the director directly owned 6,660 shares of Charles Schwab common stock and indirectly held 97,959.7662 shares through a trust.
The explanation notes that the shares received upon exercise were contributed to a revocable trust and that the indirect holdings include 277.8338 shares acquired via dividend reinvestment. The option was originally granted under the Directors' Deferred Compensation Plan II and vested immediately, and after this exercise the report shows 0 derivative securities of this option remaining.
Charles Schwab Corp director reports share transfer
A director of Charles Schwab Corp (SCHW) reported a transaction in company stock dated 11/19/2025. The filing shows a transaction coded "G" for 8,372 shares of common stock at a price of $0, which typically indicates a gift or similar transfer for no consideration. After this transaction, the director reports beneficial ownership of 9,778.6867 shares held directly, 9,662.1247 shares held indirectly through an IRA, and 3,493.6468 shares held indirectly through a 401(k) plan.
The reported direct and indirect positions include shares acquired through dividend reinvestment: 40.3393 shares in the direct account, 27.3683 shares in the IRA, and 9.8959 shares in the 401(k). This Form 4 provides an updated snapshot of the director’s holdings in Schwab stock, distinguishing between direct ownership and retirement-related accounts.
Charles Schwab Corp (SCHW) reported an insider equity change involving its Chief Risk Officer. On 11/12/2025, the officer reported a Form 4 transaction coded "G" in common stock, indicating a gift or similar transfer. The filing shows 1,032.4013 shares of common stock disposed of at a stated price of $0, leaving 57,972.4846 shares beneficially owned directly after the transaction. The officer also reports an additional 2,374 shares held indirectly through an employee stock purchase plan (ESPP). The position includes 5.6553 shares that were acquired through dividend reinvestment, highlighting ongoing participation in Schwab equity programs.
Charles Schwab Corporation (SCHW) reported an insider equity transaction by its MD, Head of Advisor Services. On 11/12/2025, the executive exercised a nonqualified stock option to acquire 3,072 shares of common stock at $46.39 per share, then contributed those shares to a trust. That same day, the trust sold 3,072 shares of common stock at $98 per share under a pre-arranged Rule 10b5-1 trading plan adopted on May 28, 2025. Following these transactions, the executive directly owned 43,340 shares of Schwab common stock and the trust beneficially owned 11,923 shares, with 4,000 stock options remaining outstanding and held directly.
Charles Schwab Corp (SCHW) director reports a stock gift. A reporting person serving as a director transferred 8,680 shares of Charles Schwab common stock on 11/13/2025 in a transaction coded "G," which indicates a gift, at a stated price of $0 per share. After this transaction, the director reports beneficial ownership of 96,974.1605 shares held indirectly through a trust and an additional 8,073 shares held directly.